Saunders R, et al. - Researchers investigated how the use of small bowel and colon video capsule endoscopy (SBC) for scheduled monitoring of Crohn disease (CD) influences the expense as well as outcomes of the patients. They evaluated 2 monitoring scenarios: common monitoring practice (CMP) for CD (ileocolonoscopy plus imaging) in the first scenario and conversion of patients to disease monitoring using SBC in the second scenario. With SBC vs CMP, increased quality of life was observed in all patient groups; active symptomatic patients exhibited the highest gain. Reduced costs ($313,367 vs $320,015), increased life expectancy (18.15 vs 17.9 years) and increased quality of life (8.7 vs 8.0 QALY) were provided by SBC, as observed over 20 years. The yearly savings were $1135 per SBC-patient. Over 5 years, $36.5 million was the total savings for the payer. Overall, SBC was considered as a likely cost-effective and cost-saving strategy for monitoring CD in the US.